Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients ≥ 18 years of age with relapsing remitting multiple sclerosis or a clinically isolated syndrome and an expanded disability status scale score ≤5.
Patients must be on treatment with Betaferon and tolerate Betaferon according to the investigator's evaluation, but should not have received Betaferon longer than six months.
Written informed consent must be obtained
You may not be if
Patients who do not tolerate Betaferon according to the investigator's evaluation or have been treated with Betaferon for more than six months.
Patients receiving any other disease modifying drug or MS specific treatments
Contraindications of Betaferon described in the Summary of Product Characteristics.
Clareo Health | Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon
